GlassScriptPhysician profile
Jeffrey K Chacko
NPI 1700024064
$2,651.63
in general payments reported to CMS, 2019-2025
24 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $186 · 2021: $390 · 2022: $445 · 2023: $631 · 2024: $128 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $323.80 | 2019-2021 | |
| Fidia Pharma USA INC. | $276.16 | 2019-2024 | Hyalgan |
| Boston Scientific Corporation | $266.94 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $263.57 | 2021-2025 | Gelsyn-3, Supartz Fx Sodium Hyaluronate |
| Nevro Corp. | $254.45 | 2021-2023 | Senza |
| Si-Bone, INC. | $237.97 | 2019-2021 | |
| Depuy Synthes Sales INC. | $198.92 | 2019-2024 | Orthovisc |
| Kowa Pharmaceuticals America, INC. | $194.81 | 2022-2023 | Seglentis |
| Relievant Medsystems, INC. | $147.37 | 2022 | |
| Scilex Pharmaceuticals INC. | $104.80 | 2022-2023 | Ztlido |
| Neuronetics, INC. | $61.91 | 2021-2022 | |
| Globus Medical, INC. | $47.23 | 2025 | Senza |
| Saluda Medical Americas, INC. | $46.54 | 2025 | Evoke |
| Ferring Pharmaceuticals INC. | $43.92 | 2023 | Euflexxa |
| Forte Bio-Pharma LLC | $31.81 | 2025 | Prolate, Nalocet, Tanlor |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $31.53 | 2023 | Gps III Platelet Concentration System |
| Medtronic USA, INC. | $17.71 | 2019 | |
| Flowonix Medical Incorporated | $17.15 | 2019 | |
| Abbott Laboratories | $15.36 | 2021 | |
| Pacira Therapeutics, INC. | $15.00 | 2019 | |
| Allergan, INC. | $14.36 | 2021 | |
| Pfizer INC. | $13.92 | 2020 | |
| Azurity Pharmaceuticals, INC. | $13.75 | 2024 | Horizant |
| Carolina Liquid Chemistries Corp | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.